FDA-Drug2014-07-23Class III
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Sold states
Nationwide
Affected count
1104 blister packs
Manufactured in
1090 Horsham Rd, N/A, North Wales, PA, United States
Products
Apri (desogestrel and ethinyl estradiol tablets USP), 0.15 mg/0.03 mg, 6 Cyclic dispensers X 28 tablets, Rx only, Teva Pharmaceuticals, Sellersville, PA. NDC 0555-9043-58
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1436-2014Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief